UBS AM’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,593
| Closed | -$304K | – | 2717 |
|
|
2025
Q1 | $304K | Sell |
33,593
-2,157
| -6% | -$19.5K | ﹤0.01% | 2555 |
|
|
2024
Q4 | $618K | Buy |
35,750
+21,594
| +153% | +$373K | ﹤0.01% | 2515 |
|
|
2024
Q3 | $226K | Buy |
14,156
+3,644
| +35% | +$58.2K | ﹤0.01% | 2752 |
|
|
2024
Q2 | $150K | Buy |
+10,512
| New | +$150K | ﹤0.01% | 2766 |
|